Literature DB >> 31146671

Design, Synthesis and Evaluation of 8-Thiosubstituted 1,3,7- Trimethylxanthine Hydrazones with In-vitro Neuroprotective and MAO-B Inhibitory Activities.

Javor Mitkov1, Alexandra Kasabova-Angelova2, Magdalena Kondeva-Burdina2, Virginia Tzankova2, Diana Tzankova1, Maya Georgieva1, Alexander Zlatkov1.   

Abstract

OBJECTIVE: The syntheses and biological activities of 8-thiosubstituted-1,3,7- trimethylxanthine derivatives bearing an aromatic hydrazide-hydrazone fragment in the side chain at C8 are described.
METHODS: The chemical structures of the synthesized compounds 6a-m were confirmed based on their MS, FTIR, 1H NMR and 13C NMR analyses.
RESULTS: The in vitro investigations of neuroprotective effects manifested on cellular (human neuroblastoma cell line SH-SY5Y) and sub-cellular (isolated rat brain synaptosomes) levels show that compounds 6g and 6i demonstrate statistically significant activity. The performed monoamine oxidase B (MAO-B) inhibition study in vitro show that compounds 6g and 6i possess a significant MAO-B inhibition activity close to L-deprenyl.
CONCLUSION: These results suggest that such compounds may be utilized for the development of new candidate MAO-B inhibitors for the treatment of Parkinson's disease. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Alzheimer's disease; Parkinson’szzm321990disease; SH-SY5Y; aromatic hydrazide-hydrazones; monoamine oxidase B; xanthine.

Year:  2020        PMID: 31146671     DOI: 10.2174/1573406415666190531121927

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  1 in total

1.  Review of medicine utilization for Parkinson's disease management: the Bulgarian perspective.

Authors:  Zornitsa Mitkova; Maria Kamusheva; Dobrinka Kalpachka; Desislava Ignatova; Konstantin Tachkov; Guenka Petrova
Journal:  J Public Health Res       Date:  2021-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.